首页> 外文期刊>International Journal of Nanomedicine >Theranostic Nanoparticles with Aggregation-Induced Emission and MRI Contrast Enhancement Characteristics as a Dual-Modal Imaging Platform for Image-Guided Tumor Photodynamic Therapy
【24h】

Theranostic Nanoparticles with Aggregation-Induced Emission and MRI Contrast Enhancement Characteristics as a Dual-Modal Imaging Platform for Image-Guided Tumor Photodynamic Therapy

机译:具有聚集诱导的发射和MRI对比增强特性作为用于图像引导肿瘤光动力疗法的双模型成像平台的治疗纳米粒子

获取原文
           

摘要

Introduction: Advanced tumor-targeted theranostic nanoparticles play a key role in tumor diagnosis and treatment research. In this study, we developed a multifunctional theranostic platform based on an amphiphilic hyaluronan/poly-( N -?-carbobenzyloxy-L-lysine) derivative (HA- g -PZLL), superparamagnetic iron oxide (SPIO) and aggregation-induced emission (AIE) nanoparticles for tumor-targeted magnetic resonance (MR) and fluorescence (FL) dual-modal image-guided photodynamic therapy (PDT). Materials and Methods: The amphiphilic hyaluronan acid (HA) derivative HA- g -PZLL was synthesized by grafting hydrophobic poly-( N -?-carbobenzyloxy-L-lysine) (PZLL) blocks onto hyaluronic acid by a click conjugation reaction. The obtained HA- g -PZLLs self-assembled into nanoparticles in the presence of AIE molecules and SPIO nanoparticles to produce tumor-targeted theranostic nanoparticles (SPIO/AIE@HA- g -PZLLs) with MR/FL dual-modal imaging ability. Cellular uptake of the theranostic nanoparticles was traced by confocal laser scanning microscopy (CLSM), flow cytometry and Prussian blue staining. The intracellular reactive oxygen species (ROS) generation characteristics of the theranostic nanoparticles were evaluated with CLSM and flow cytometry. The effect of PDT was evaluated by cytotoxicity assay. The dual-mode imaging ability of the nanoparticles was evaluated by a real-time near-infrared fluorescence imaging system and magnetic resonance imaging scanning. Results: The resulting theranostic nanoparticles not only emit red fluorescence for high-quality intracellular tracing but also effectively produce singlet oxygen for photodynamic tumor therapy. In vitro cytotoxicity experiments showed that these theranostic nanoparticles can be efficiently taken up and are mainly present in the cytoplasm of HepG2 cells. After internalization, these theranostic nanoparticles showed serious cytotoxicity to the growth of HepG2 cells after white light irradiation. Discussion: This work provides a simple method for the preparation of theranostic nanoparticles with AIE characteristics and MR contrast enhancement, and serves as a dual-modal imaging platform for image-guided tumor PDT.
机译:介绍:晚期肿瘤靶向治疗纳米粒子在肿瘤诊断和治疗研究中起着关键作用。在这项研究中,我们开发了基于两亲透明质酸/聚 - (N - α - Carbenzyl氧基-L-赖氨酸)衍生物(HA-G-PZLL),超顺磁性氧化铁(SPIO)和聚集诱导的发射( AIE)用于肿瘤靶向磁共振(MR)和荧光(FL)双模态图像引导光动力治疗(PDT)的纳米颗粒。材料和方法:通过点击缀合反应将疏水性聚 - (N - α - Carbobenzyl氧基-1-赖氨酸)(PZLL)块移植到透明质酸上,合成两亲透明质酸酸(HA)衍生物HA-G-PZLL。将获得的HA-G-PZLLS在AIE分子和SPIO纳米粒子存在下自组装成纳米颗粒,以产生具有MR / FL双模态成像能力的肿瘤靶向治疗的治疗纳米颗粒(SPIO / AIE @ HA-G-PZLLS)。通过共聚焦激光扫描显微镜(CLSM),流式细胞术和普鲁士蓝染色来跟踪治疗纳米粒子的细胞吸收。用CLSM和流式细胞术评价治疗纳米颗粒的细胞内反应性氧物质(ROS)产生特征。通过细胞毒性测定评估PDT的效果。通过实时近红外荧光成像系统和磁共振成像扫描评估纳米颗粒的双模成像能力。结果:由此产生的治疗纳米粒子不仅发出红色荧光,用于高质量的细胞内追踪,而且还有效地产生用于光动力肿瘤疗法的单线氧。体外细胞毒性实验表明,这些治疗纳米颗粒可以有效地升高,主要存在于HepG2细胞的细胞质中。内部化后,这些治疗纳米粒子显示出白光照射后HepG2细胞的生长的严重细胞毒性。讨论:该作品提供了一种简单的方法,用于制备具有AIE特性的治疗纳米粒子和MR对比度增强,并用作用于图像引导肿瘤PDT的双模态成像平台。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号